Company / Net Income
Bicara Therapeutics Inc. Net Income History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$68.0M
FY2024
5-year range
-$68.0M / -$52.0M
FY2023-FY2024
Trend
-30.8%
vs FY2023
Sector context
#90 of 216
Health Care
What the data says
At -$68M, Bicara Therapeutics Inc.'s net income ranks #90 of 216 in the Health Care sector.
Based on SEC 10-K filings.
-$68M in FY2024.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 216 in Health CareTop 42% of 216This company -$68.0M Sector average $454.1M
▼
-115.0% below sector average
Key checks
Key Insights
- In FY2024, net income decreased 30.8% year-over-year.
- Ranks #90 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$68.0M | -30.8% |
| FY2023 | -$52.0M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026